STOCK TITAN

Monopar Therapeutics Inc. (MNPR) Net Income by Year

MNPR

Monopar Therapeutics Inc. reported a net loss of $13.7M in fiscal year 2025. This represents an increase of 12.0% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Monopar Therapeutics Inc. has filed alongside them.

FY2025 annual
Net Income -$13.7M
YoY +12.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MNPR Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-K
Net Income-$13.7M+12.0%-$15.6M-85.5%-$8.4M+20.1%-$10.5M-15.5%-$9.1M-44.4%-$6.3M-49.2%-$4.2M-30.9%-$3.2M+80.5%-$16.6M-1296.3%-$1.2M

MNPR Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$5.3M-116.6%-$3.9M-48.3%N/A-$3.4M-163.6%-$2.5M-43.0%-$2.6M-59.9%N/A-$1.3M+33.2%-$1.7M+22.0%-$1.6M+32.6%N/A-$2.0M+18.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Monopar Therapeutics Inc. financials

Frequently Asked Questions

What was Monopar Therapeutics Inc.'s net income in fiscal year 2025?

Monopar Therapeutics Inc. reported a net loss of $13.7M in fiscal year 2025.

How fast is Monopar Therapeutics Inc.'s net income growing?

Monopar Therapeutics Inc. (MNPR) net income rose by 12.0% year over year, from -$15.6M to -$13.7M in fiscal year 2025.

How has Monopar Therapeutics Inc.'s net income changed over the years?

Across the 10 fiscal years this page covers, Monopar Therapeutics Inc. (MNPR) net income went from -$1.2M in fiscal year 2016 to -$13.7M in fiscal year 2025.

Monopar Therapeutics Inc. (MNPR) reported -$5.3M in net income in Q2 2026. This represents a decrease of 116.6% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Monopar Therapeutics Inc. (MNPR) reported on that line in every period on record.